Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Further studies are needed to evaluate the potential benefits of Farnesoid X Receptor (FXR / NR1H4) Agonists in human Alcohol-associated Liver Disease (ALD) patients
Pruritus and hypercholesterolemia may also be potential undesirable effects in the chronic use of FXR agonist in Alcohol-associated Liver Disease (ALD)
Li & Chiang 2020 Hepatobiliary Surg. Nutr. 9: 1…